Cormorant Asset Management »

Rallybio Corp shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Rallybio Corp (RLYB) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Rallybio Corp

Tip: Access up to 7 years of quarterly data

All positions including Rallybio Corp held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rallybio Corp by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 400k 8.97

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Eyepoint Com New (EYPT)
Edgewise Therapeutics (EWTX)
Erasca (ERAS)
Rapport Therapeutics (RAPP)
Alumis (ALMS)
Abivax Sa Sponsored Ads (ABVX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Dianthus Therapeutics (DNTH)
Bright Minds Biosciences Com New (DRUG)
Olema Pharmaceuticals (OLMA)
Bridgebio Pharma (BBIO)
Bioage Labs (BIOA)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Cormorant Asset Management

Top funds holding Rallybio Corp

Viking Global Investors
Cormorant Asset Management
Tpg Gp A
Balyasny Asset Management
Nantahala Capital Management
5AM Venture Management
Almitas Capital
Johnson & Johnson
Vanguard Capital Management
AJU IB Investment
Mariner Wealth Advisors
Geode Capital Management
Deltec Asset Management
Rangeley Capital
ADAR1 Capital Management

View all funds holding Rallybio Corp